Logo image of HLGN

HELIOGEN INC (HLGN) Stock Fundamental Analysis

NYSE:HLGN - New York Stock Exchange, Inc. - US42329E2046 - Common Stock - Currency: USD

2.45  +0.1 (+4.26%)

Fundamental Rating

3

HLGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 93 industry peers in the Electrical Equipment industry. HLGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HLGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HLGN had negative earnings in the past year.
HLGN had a negative operating cash flow in the past year.
HLGN Yearly Net Income VS EBIT VS OCF VS FCFHLGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M

1.2 Ratios

The Return On Assets of HLGN (-61.75%) is worse than 88.51% of its industry peers.
Looking at the Return On Equity, with a value of -107.61%, HLGN is doing worse than 77.01% of the companies in the same industry.
Industry RankSector Rank
ROA -61.75%
ROE -107.61%
ROIC N/A
ROA(3y)-55.04%
ROA(5y)N/A
ROE(3y)-72.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLGN Yearly ROA, ROE, ROICHLGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of HLGN (6.98%) is worse than 67.82% of its industry peers.
HLGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HLGN Yearly Profit, Operating, Gross MarginsHLGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -1K -2K -3K

More info and screens

6

2. Health

2.1 Basic Checks

HLGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HLGN has been increased compared to 1 year ago.
HLGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HLGN Yearly Shares OutstandingHLGN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 50M 100M 150M
HLGN Yearly Total Debt VS Total AssetsHLGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

HLGN has an Altman-Z score of -4.33. This is a bad value and indicates that HLGN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -4.33, HLGN is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
HLGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.33
ROIC/WACCN/A
WACC11.31%
HLGN Yearly LT Debt VS Equity VS FCFHLGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

2.3 Liquidity

HLGN has a Current Ratio of 2.43. This indicates that HLGN is financially healthy and has no problem in meeting its short term obligations.
HLGN has a Current ratio (2.43) which is in line with its industry peers.
A Quick Ratio of 2.35 indicates that HLGN has no problem at all paying its short term obligations.
HLGN has a better Quick ratio (2.35) than 77.01% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.35
HLGN Yearly Current Assets VS Current LiabilitesHLGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HLGN have decreased strongly by -1330.78% in the last year.
HLGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.62%.
EPS 1Y (TTM)-1330.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)-16.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.72%

3.2 Future

The Earnings Per Share is expected to grow by 36.39% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 163.58% on average over the next years. This is a very strong growth
EPS Next Y13.38%
EPS Next 2Y-0.44%
EPS Next 3Y26.69%
EPS Next 5Y36.39%
Revenue Next Year114.44%
Revenue Next 2Y219.55%
Revenue Next 3Y254.29%
Revenue Next 5Y163.58%

3.3 Evolution

HLGN Yearly Revenue VS EstimatesHLGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
HLGN Yearly EPS VS EstimatesHLGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HLGN. In the last year negative earnings were reported.
Also next year HLGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HLGN Price Earnings VS Forward Price EarningsHLGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HLGN Per share dataHLGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

HLGN's earnings are expected to grow with 26.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.44%
EPS Next 3Y26.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HLGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HELIOGEN INC

NYSE:HLGN (11/7/2023, 8:04:01 PM)

2.45

+0.1 (+4.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change-9.81%
Ins Owners122.28%
Ins Owner Change-0.1%
Market Cap14.41M
Analysts77.78
Price Target16.07 (555.92%)
Short Float %2.5%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.29%
Min EPS beat(2)-9.75%
Max EPS beat(2)42.33%
EPS beat(4)2
Avg EPS beat(4)9.36%
Min EPS beat(4)-24.02%
Max EPS beat(4)42.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-67.81%
Min Revenue beat(2)-69.29%
Max Revenue beat(2)-66.34%
Revenue beat(4)1
Avg Revenue beat(4)-41.93%
Min Revenue beat(4)-69.29%
Max Revenue beat(4)16.14%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3400%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4244.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-4088.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-40.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-15.4
EYN/A
EPS(NY)-15.89
Fwd EYN/A
FCF(TTM)-14.16
FCFYN/A
OCF(TTM)-13.07
OCFYN/A
SpS1.9
BVpS15.02
TBVpS15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.75%
ROE -107.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.98%
FCFM N/A
ROA(3y)-55.04%
ROA(5y)N/A
ROE(3y)-72.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 275.2%
Cap/Sales 57.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.35
Altman-Z -4.33
F-Score5
WACC11.31%
ROIC/WACCN/A
Cap/Depr(3y)414.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)85.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1330.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y13.38%
EPS Next 2Y-0.44%
EPS Next 3Y26.69%
EPS Next 5Y36.39%
Revenue 1Y (TTM)-16.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.72%
Revenue Next Year114.44%
Revenue Next 2Y219.55%
Revenue Next 3Y254.29%
Revenue Next 5Y163.58%
EBIT growth 1Y-1.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.92%
EBIT Next 3Y32.86%
EBIT Next 5Y38.15%
FCF growth 1Y-126.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.88%
OCF growth 3YN/A
OCF growth 5YN/A